# IMPART: A Provider-Assisted HIV Partner Notification & Testing Intervention for Prisoners in Indonesia.

> **NIH NIH R34** · UNIVERSITY OF ILLINOIS AT CHICAGO · 2020 · $206,128

## Abstract

This R34 responds to program announcement: Formative and Pilot Intervention Research for Prevention and
Treatment of HIV/AIDS (PA-17-166). Over half of persons living with HIV (PLWH) worldwide are undiagnosed. To
increase the number of PLWH who are aware of their status, the World Health Organization recommends that all
PLWH receive assistance to notify their at-risk sex and needle-sharing partners so they can be offered HIV testing. A
main limitation of these HIV prevention recommendations is the lack of evidence for implementing partner services
in prisons and other criminal justice settings where HIV is frequently diagnosed. To increase HIV testing among at-
risk partners, we will conduct research in Indonesia, where up to 14% of prisoners are HIV-infected, to achieve our
specific aims which are to: 1) finalize a nurse-led partner notification intervention, IMPART, that we developed for the
Indonesian prison setting, and 2) pilot IMPART for feasibility and acceptability through a clinical trail conducted in
Jakarta's two largest prisons. To prepare for implementation, we will first conduct focus groups with 32 nurses (Phase
1) to examine individual provider-level barriers that may influence nurses' readiness to conduct partner elicitation,
notification, HIV testing, and treatment referral. We will use these findings to finalize our intervention and training
protocols in collaboration with a community advisory board and content experts and pre-test IMPART with 5 HIV-
positive prisoners. In Phase 2, we will conduct a 2-arm pilot randomized controlled trial with 60 incarcerated index
patients and their sex and needle-sharing partners in the community. Participants in the Choice arm may choose nurse
provider-assistance (IMPART) to notify one or more partners, while those in the Control arm will be encouraged to
notify their partner(s) themselves. Index patients in both groups will complete questionnaires before and after the
intervention to assess HIV stigma and related psychosocial process that may influence disclosure. IMPART's
acceptability will be assessed as the number of index patients who enroll or choose provider assistance, and the number
of at-risk partners named. Feasibility will be assessed as the quality and completeness of partner locator information
and barriers to partner notification and HIV testing encountered in the study. Finally, we will compare the number of
partners in each arm who are: notified, HIV tested, newly diagnosed, and entering treatment. Structured interviews
with HIV-positive partners 2 weeks after notification will provide additional information about IMPART's acceptability.
The intervention and study design are products of a highly-qualified and interdisciplinary investigative team with
extensive research experience in the Indonesian prison setting. Findings will supply essential information for a planned
comparative effectiveness (R01) study of the IMPART intervention. If successful, this study will lead to a ...

## Key facts

- **NIH application ID:** 9968449
- **Project number:** 5R34MH115779-03
- **Recipient organization:** UNIVERSITY OF ILLINOIS AT CHICAGO
- **Principal Investigator:** Gabriel John Culbert
- **Activity code:** R34 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $206,128
- **Award type:** 5
- **Project period:** 2018-09-14 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9968449

## Citation

> US National Institutes of Health, RePORTER application 9968449, IMPART: A Provider-Assisted HIV Partner Notification & Testing Intervention for Prisoners in Indonesia. (5R34MH115779-03). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9968449. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*